Ellen O’Meara, PhD

“Our work in the Breast Cancer Surveillance Consortium is to make notable contributions to understanding cancer risk, screening effectiveness, and how to ensure the best outcomes for women with breast cancer.”

Ellen  O’Meara, PhD

Research Associate, Kaiser Permanente Washington Health Research Institute

Biography

Ellen O’Meara, PhD, came to Kaiser Permanente Washington Health Research Institute in 2009 with an array of scientific interests. The common thread across more than two decades of research experience is studying the epidemiology of common diseases in adults, such as cancer, Alzheimer's, and cardiovascular disease.

Because of her strong interests in screening for disease and outcomes after diagnosis, Dr. O’Meara is pleased to be part of the Kaiser Permanente Washington-led Statistical Coordinating Center for the Breast Cancer Surveillance Consortium—a national network of breast imaging and breast cancer researchers. One of her goals is to find ways to optimize breast cancer screening—that is, to find the best balance of benefits and risks in subgroups of women.

Dr. O’Meara’s other professional activities include membership in the Society for Epidemiologic Research and serving as a reviewer for the Journal of the National Cancer Institute.

Research interests and experience

 

Recent publications

Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI. Underutilization of supplemental magnetic resonance imaging screening among patients at high breast cancer risk. J Womens Health (Larchmt). 2018 Jan 17. doi: 10.1089/jwh.2017.6623. [Epub ahead of print]. PubMed

Hubbard RA, O'Meara ES, Henderson LM, Hill D, Braithwaite D, Haas JS, Lee CI, Sprague BL, Alford-Teaster J, Tosteson AN, Wernli KJ, Onega T. Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med. 2016 Aug;89:169-77. doi: 10.1016/j.ypmed.2016.05.034. Epub 2016 May 31. PubMed

Cushman M, O'Meara ES, Heckbert SR, Zakai NA, Rosamond W, Folsom AR. Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: the longitudinal investigation of thromboembolism etiology. Thromb Res. 2016 Jun 15;144:127-132. doi: 10.1016/j.thromres.2016.06.012. [Epub ahead of print]. PubMed

Nelson HD, O'Meara ES, Kerlikowske K, Balch S, Miglioretti DL. Factors affecting the rates and consequences of false positive and false negative digital mammography screening exams: an analysis of registry data. Ann Intern Med. 2016 Feb 16;164(4):226-35. doi: 10.7326/M15-0971. Epub 2016 Jan 12.

 

cancer

What to expect after a screening breast MRI vs. mammography alone

Diana Buist and BCSC find screening MRI leads to more biopsies, finding fewer cancers, regardless of personal history of breast cancer: JAMA Internal Medicine.

Read it in Healthy Findings

Recent News

KPWHRI shares in $17 million grant to improve breast screening

National Cancer Institute support continues nation's largest collection of breast imaging data and funds three studies to personalize screening.

Read it in News and Events

Aging & Geriatrics

Targeting risk factors could prevent 1 in 3 dementia cases

International experts on The Lancet Commission report, including Dr. Eric B. Larson, identify 9 risk factors from childhood onward.

Read about it in News and Events.

Live Healthy

Early signs of cognitive impairment? Learn about Your Life, Your Choices

If you or a loved one is experiencing cognitive impairment or even early signs of Alzheimer’s disease or another form of dementia, now is a good time to start talking with your health care providers and family members about advance care planning.

Read it in Live Healthy.